Keywords: roche, r1507, effective, ph, against, solid, tumors

Roche's R1507 effective at Ph I against solid tumors

Article | 05 November 2007

Print This

Swiss drug major Roche says that Phase I data from a trial of R1507, a monoclonal antibody that targets the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in